Home › Funds › SABBY MANAGEMENT, LLC › APVO
SABBY MANAGEMENT, LLC position in APVO
APTEVO THERAPEUTICS INC · Health Care
SABBY MANAGEMENT, LLC reported holding 232,692 shares of APVO (APTEVO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$423K, representing 9.41% of its reported portfolio and ranking #4 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed APVO holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SABBY MANAGEMENT, LLC's APVO position evolved
SABBY MANAGEMENT, LLC first disclosed a stake in APVO in Q3 2023 at 1,334,169 shares (US$440.3M). Across 4 filings, SABBY MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 232,692 shares valued at US$423K. Notable position changes include a 74% trim in Q4 2023 (shares fell 41% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.33M | $440.28M | New |
| Q4 2023 | 349.47K | $63.25M | Reduce |
| Q2 2024 | 501.50K | $153.46K | New |
| Q3 2026 | 232.69K | $423.50K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About APVO and 13F data
APVO (APTEVO THERAPEUTICS INC) is a Health Care company. 10 other funds we track also report a position in APVO. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on SABBY MANAGEMENT, LLC
FAQ
How long has SABBY MANAGEMENT, LLC held APVO?
SABBY MANAGEMENT, LLC has disclosed APVO holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is SABBY MANAGEMENT, LLC's current position in APVO?
As of Q3 2026, SABBY MANAGEMENT, LLC holds 232.69K shares of APVO (APTEVO THERAPEUTICS INC), valued at $423.50K, representing 9.41% of its reported portfolio and ranking #4.
Has SABBY MANAGEMENT, LLC been buying or selling APVO?
In the latest 13F filing (Q3 2026), SABBY MANAGEMENT, LLC newly opened its position in APVO.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.